Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
N/A
-1,864,893 Closed
0 $0
Q2 2023

Aug 14, 2023

SELL
N/A
-549,104 Closed
0 $0
Q3 2022

Nov 13, 2023

BUY
$22.17 - $51.8 $41.3 Million - $96.6 Million
1,864,893 New
1,864,893 $96.3 Million
Q2 2022

Aug 14, 2023

BUY
$15.36 - $27.51 $8.43 Million - $15.1 Million
549,104 New
549,104 $13.6 Million
Q1 2022

May 12, 2023

BUY
$22.22 - $39.12 $25.3 Million - $44.6 Million
1,139,940 New
1,139,940 $28.6 Million
Q1 2022

May 09, 2022

SELL
$22.22 - $39.12 $24.4 Million - $43 Million
-1,099,824 Closed
0 $0
Q4 2021

Mar 09, 2022

BUY
$18.38 - $40.5 $20.2 Million - $44.5 Million
1,099,824 New
1,099,824 $40 Million
Q3 2021

Nov 14, 2022

BUY
$13.18 - $19.83 $4.68 Million - $7.04 Million
354,914 New
354,914 $6.07 Million
Q3 2021

Nov 05, 2021

SELL
$13.18 - $19.83 $5.78 Million - $8.7 Million
-438,824 Closed
0 $0
Q2 2021

Aug 15, 2022

BUY
$9.59 - $50.88 $4.21 Million - $22.3 Million
438,824 New
438,824 $5.88 Million
Q2 2021

Aug 10, 2021

SELL
$9.59 - $50.88 $1.64 Million - $8.7 Million
-171,055 Closed
0 $0
Q1 2021

May 09, 2022

BUY
$49.53 - $68.4 $8.47 Million - $11.7 Million
171,055 New
171,055 $8.77 Million
Q1 2021

May 07, 2021

SELL
$49.53 - $68.4 $23 Million - $31.7 Million
-464,097 Closed
0 $0
Q4 2020

Mar 02, 2021

BUY
$47.25 - $65.16 $21.9 Million - $30.2 Million
464,097 New
464,097 $28.7 Million
Q4 2020

Feb 10, 2021

SELL
$47.25 - $65.16 $25 Million - $34.4 Million
-528,664 Closed
0 $0
Q3 2020

Nov 12, 2021

BUY
$46.35 - $61.69 $24.5 Million - $32.6 Million
528,664 New
528,664 $29 Million
Q3 2020

Nov 10, 2020

SELL
$46.35 - $61.69 $25.2 Million - $33.5 Million
-542,702 Closed
0 $0
Q2 2020

Aug 13, 2021

BUY
$38.58 - $65.07 $20.9 Million - $35.3 Million
542,702 New
542,702 $31.2 Million
Q2 2020

Aug 07, 2020

SELL
$38.58 - $65.07 $17.4 Million - $29.4 Million
-451,161 Closed
0 $0
Q1 2020

May 07, 2021

BUY
$32.73 - $50.78 $14.8 Million - $22.9 Million
451,161 New
451,161 $18.1 Million

Others Institutions Holding CCXI

About ChemoCentryx, Inc.


  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.